Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01628
|
|||||
| Drug Name |
Guanfacine
|
|||||
| Synonyms |
GUANFACINE; Tenex; Guanfacinum [INN-Latin]; Guanfacina [INN-Spanish]; Estulic; Intuniv; N-amidino-2-(2,6-dichlorophenyl)acetamide; CHEBI:5558; INJOMKTZOLKMBF-UHFFFAOYSA-N; SPD 503; C9H9Cl2N3O; N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide; N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide; Guanfacine Monohydrochloride; NCGC00015469-05; Lon798; Guanfacine (INN); Estulic (TN); Tenex (Salt/Mix); Estulic (Salt/Mix); Tocris-1030; Prestwick1_000339; Prestwick3_000339; Prestwick2_000339; Prestwick0_000339; Lopac-G-1043
|
|||||
| Indication | Primary liver cancer [ICD11: 2C12.0] | Phase 4 | [1] | |||
| Stress disorder [ICD11: 6B40] | Phase 4 | [1] | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C9H9Cl2N3O
|
|||||
| Canonical SMILES |
C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl
|
|||||
| InChI |
InChI=1S/C9H9Cl2N3O/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13/h1-3H,4H2,(H4,12,13,14,15)
|
|||||
| InChIKey |
INJOMKTZOLKMBF-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 29110-47-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 246.09 | Topological Polar Surface Area | 81.5 | ||
| Heavy Atom Count | 15 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 1 | |||
| XLogP |
2
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:5558
|
|||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03258476) Guanfacine Extended Release and Mindfulness Skills Therapy | |||||
| 2 | An in vitro evaluation of guanfacine as a substrate for P-glycoprotein. Neuropsychiatr Dis Treat. 2011;7:501-5. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.